ROYALTY PHARMA PLC shareholders Q2 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$104,262,51846.16%
Indie Asset Partners, LLC 433,000$13,310,42014.48%
Vantage Consulting Group Inc 650,690$20,002,21111.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$93,666,2865.01%
Advanced Portfolio Management, LLC 150,000$4,611,0004.20%
Overbrook Management Corp 553,717$17,021,2614.04%
Compound Global Advisors, LLC 543,920$16,720,1013.86%
Geo Capital Gestora de Recursos Ltd 130,487$4,0113.11%
TORRAY INVESTMENT PARTNERS LLC 413,815$12,720,6732.20%
Lagoda Investment Management, L.P. 57,180$1,757,7131.24%
VIKING GLOBAL INVESTORS LP 9,850,932$302,817,6501.24%
Greytown Advisors Inc. 69,191$2,126,9311.16%
HOMESTEAD ADVISERS CORP 1,322,040$40,639,5101.08%
GENERAL ATLANTIC, L.P. 1,500,000$46,110,0000.73%
Marathon Asset Management Ltd 803,167$24,688,7300.69%
CWA Asset Management Group, LLC 326,087$10,023,9270.69%
Aurora Investment Counsel 34,330$1,055,3040.68%
Neo Ivy Capital Management 38,961$1,1980.63%
ADAGE CAPITAL PARTNERS GP, L.L.C. 8,650,000$265,901,0000.58%
S&CO INC 224,220$6,8920.56%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.